Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 137241000087110 | CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 95651000087116 | CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 95661000087118 | HPV-2 CERVARIX GSK | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 97021000087111 | VPH-2 CERVARIX GSK | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only Human papillomavirus 2 serotypes antigens (medicinal product) | false | Inferred relationship | Some | ||
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Human papillomavirus type 16 L1 capsid protein antigen | true | Inferred relationship | Some | 1 | |
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | true | Inferred relationship | Some | ||
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Human papillomavirus type 18 L1 capsid protein antigen | true | Inferred relationship | Some | 2 | |
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Count of active ingredient | deux | false | Inferred relationship | Some | ||
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only Human papillomavirus 16 and 18 antigens (medicinal product) | true | Inferred relationship | Some | ||
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Human papillomavirus vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR